Ardelyx: Pay

Ardelyx paid its 6 named executives $23.2M in total in FY2025 (Dec). CEO Michael Raab was paid $7.8M of that.

Pay$100 in the stock at the end of FY21 → $530
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Michael RaabPresident, Chief Executive Officer and Director
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Edward Conner, M.D.Former Chief Medical Officer
FY2025 (Dec)
1 year
Justin RenzFormer Chief Financial and Operations Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Susan HohenleitnerChief Financial Officer
FY2025 (Dec)
1 year
John Bishop, Ph.D.Chief Technical and Quality Officer
FY2025 (Dec)
1 year
Elizabeth Grammer, Esq.Former Chief Legal and Administrative Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $7.8M. The CEO of Ardelyx was paid $7.8M, 1% below the median.

  1. 1Ocular Therapeutix
  2. 2TG Therapeutics
  3. 3Mirum Pharmaceuticals
  4. 4Adma Biologics
  5. 5Travere Therapeutics
  6. 6Ardelyx
  7. 7Arcutis Biotherapeutics
  8. 8Tarsus Pharmaceuticals
  9. 9Evolus
  10. 10Innoviva
  11. 11Collegium Pharmaceutical
  12. 12Amicus Therapeutics, Inc.Not disclosed
  13. 13Biocryst PharmaceuticalsNot disclosed
  14. 14Catalyst Pharmaceuticals, Inc.Not disclosed
  15. 15Dynavax Technologies CorporationNot disclosed
  16. 16Ironwood Pharmaceuticals, Inc.Not disclosed
  17. 17MannkindNot disclosed
  18. 18Rhythm PharmaceuticalsNot disclosed
  19. 19VericelNot disclosed
  20. 20XencorNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.